Xiaodong Ling

579 total citations
34 papers, 371 citations indexed

About

Xiaodong Ling is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaodong Ling has authored 34 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaodong Ling's work include Cancer Immunotherapy and Biomarkers (10 papers), RNA modifications and cancer (10 papers) and Ferroptosis and cancer prognosis (8 papers). Xiaodong Ling is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), RNA modifications and cancer (10 papers) and Ferroptosis and cancer prognosis (8 papers). Xiaodong Ling collaborates with scholars based in China and United States. Xiaodong Ling's co-authors include Jianqun Ma, Jinhong Zhu, Yingnan Yang, Kui Cao, Junqing Gan, Jinfeng Zhang, Yanzhong Xin, Xiangyu Jiang, Dayong Zheng and Lisha Li and has published in prestigious journals such as Journal of Clinical Oncology, The Science of The Total Environment and Scientific Reports.

In The Last Decade

Xiaodong Ling

31 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaodong Ling China 12 219 141 93 77 71 34 371
Daniela Esposito Italy 11 150 0.7× 66 0.5× 70 0.8× 68 0.9× 76 1.1× 13 330
Wenjun Jiang China 14 224 1.0× 92 0.7× 66 0.7× 49 0.6× 49 0.7× 20 380
Nadeem S. Bhat United States 14 337 1.5× 230 1.6× 104 1.1× 126 1.6× 91 1.3× 26 552
Haoxuan Wu China 13 213 1.0× 115 0.8× 101 1.1× 122 1.6× 66 0.9× 29 438
Yuxin Wen China 11 265 1.2× 194 1.4× 73 0.8× 55 0.7× 24 0.3× 17 428
Chih‐Yi Chen Taiwan 11 398 1.8× 133 0.9× 150 1.6× 150 1.9× 48 0.7× 20 600
Manfei Si China 7 157 0.7× 83 0.6× 84 0.9× 49 0.6× 24 0.3× 13 392
Zhenxiong Zhao China 11 194 0.9× 132 0.9× 36 0.4× 217 2.8× 41 0.6× 20 414

Countries citing papers authored by Xiaodong Ling

Since Specialization
Citations

This map shows the geographic impact of Xiaodong Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Ling more than expected).

Fields of papers citing papers by Xiaodong Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Ling. The network helps show where Xiaodong Ling may publish in the future.

Co-authorship network of co-authors of Xiaodong Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong Ling. A scholar is included among the top collaborators of Xiaodong Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong Ling. Xiaodong Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ma, Jianqun, Ping Zhang, Yuning Wang, et al.. (2024). LncRNA HAR1A inhibits non-small cell lung cancer growth by downregulating c-MYC transcripts and facilitating its proteasomal degradation. International Immunopharmacology. 142(Pt B). 113264–113264. 1 indexed citations
4.
Ling, Xiaodong, et al.. (2024). A comprehensive prognostic and immunological implications of PFKP in pan-cancer. Cancer Cell International. 24(1). 310–310. 2 indexed citations
5.
Yin, Hang, Siyu Wang, Shijie Zhang, et al.. (2024). Breastfeeding may reduce the effects of maternal smoking on lung cancer mortality in adult offspring: a prospective cohort study. International Journal of Surgery. 110(8). 4767–4774. 1 indexed citations
6.
Ling, Xiaodong, Cuicui Qi, Kui Cao, et al.. (2024). METTL3-mediated deficiency of lncRNA HAR1A drives non-small cell lung cancer growth and metastasis by promoting ANXA2 stabilization. Cell Death Discovery. 10(1). 203–203. 7 indexed citations
7.
Chen, Guoxin, et al.. (2024). Experimental and numerical study on explosion resistance of polyurea-coated shelter in petrochemical industry. Scientific Reports. 14(1). 20643–20643.
8.
Hu, Xiang, Jian Cao, Huilin Li, et al.. (2023). 424P Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer: Updated survival results from the phase II PICTURE trial. Annals of Oncology. 34. S360–S361. 1 indexed citations
9.
10.
He, Yunlong, Qijia Xuan, Xiaodong Ling, et al.. (2022). TMEM139 prevents NSCLC metastasis by inhibiting lysosomal degradation of E‐cadherin. Cancer Science. 113(6). 1999–2007. 7 indexed citations
11.
Zhang, Jinfeng, et al.. (2022). Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma. Cellular & Molecular Biology Letters. 27(1). 39–39. 15 indexed citations
12.
Ling, Xiaodong, et al.. (2022). Hypoxia-induced oxidative stress and apoptosis in gills of scaleless carp (Gymnocypris przewalskii). Fish Physiology and Biochemistry. 48(4). 911–924. 15 indexed citations
13.
Wang, Xiaoyuan, Xiaodong Ling, Changhong Wang, et al.. (2022). Response to neoadjuvant immune checkpoint inhibitors and chemotherapy in Chinese patients with esophageal squamous cell carcinoma: the role of tumor immune microenvironment. Cancer Immunology Immunotherapy. 72(6). 1619–1631. 10 indexed citations
14.
Cao, Kui, Xiaodong Ling, Xiangyu Jiang, Jianqun Ma, & Jinhong Zhu. (2022). Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma. Respiratory Research. 23(1). 306–306. 12 indexed citations
15.
16.
Yin, Hang, Xiaoyuan Wang, Xiaodong Ling, et al.. (2021). Integrated analysis of immune infiltration in esophageal carcinoma as prognostic biomarkers. Annals of Translational Medicine. 9(22). 1697–1697. 8 indexed citations
17.
Ling, Xiaodong, et al.. (2021). The presence of polystyrene nanoplastics enhances the MCLR uptake in zebrafish leading to the exacerbation of oxidative liver damage. The Science of The Total Environment. 818. 151749–151749. 31 indexed citations
18.
Cao, Kui, Tianjiao Ma, Xiaodong Ling, et al.. (2021). Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer. Annals of Translational Medicine. 9(20). 1591–1591. 8 indexed citations
19.
Ma, Jianqun, Jinfeng Zhang, Yingnan Yang, et al.. (2021). 405 Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): a phase II, single-arm, exploratory research. Regular and Young Investigator Award Abstracts. A436–A436. 1 indexed citations
20.
Li, Shumin, Peng Huang, Junqing Gan, et al.. (2019). Dihydroartemisinin represses esophageal cancer glycolysis by down-regulating pyruvate kinase M2. European Journal of Pharmacology. 854. 232–239. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Esposito Breakdown of academic impact, for papers by Wenjun Jiang Breakdown of academic impact, for papers by Nadeem S. Bhat Breakdown of academic impact, for papers by Haoxuan Wu Breakdown of academic impact, for papers by Yuxin Wen Breakdown of academic impact, for papers by Chih‐Yi Chen Breakdown of academic impact, for papers by Manfei Si Breakdown of academic impact, for papers by Zhenxiong Zhao
Rankless by CCL
2026